You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/2517
Title: 
Long-term stability studies on protection against Newcastle disease by commercial live vaccine used in Brazil
Author(s): 
Institution: 
  • Universidade Estadual de Campinas (UNICAMP)
  • Minist Agr
  • Ctr Brazilian Anim Res
  • Universidade Estadual Paulista (UNESP)
  • Feevale Univ Ctr
ISSN: 
1045-1056
Abstract: 
The thermostability (TS) and efficacy offered by live vaccines against Newcastle disease strains B 1, La Sota, VG-GA and Ulster, produced or imported by four Brazilian laboratories, were evaluated during their validity period. Kinetic profiles were obtained from samples conserved in refrigerators during 0, 4, 8, 12, 16, 20 and 24 months after their manufacturing. The statistical analysis of the vaccine titre effect obtained by the fresh air (FA) method showed that the vaccine profiles were parallel and coincident, presenting a significant descending trend. The vaccine titres and efficiency proofs at the end of the validity period were above the level of legislation requirements and showed an average loss in titre of 0.40 and 0.66 log(10), within the first and second validity years, respectively. The titre obtained by TS, within the month after manufacturing, had no significant difference from the titre obtained by FA within 24 months after manufacturing, being their pairs of observations positively correlated (r = 0,49, p = 0.0003), showing that the TS method, which anticipates the vaccines' performance at the end of the validity period, can substitute the FA method 24 months after manufacturing. (C) 2009 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
Issue Date: 
1-Aug-2009
Citation: 
Biologicals. London: Academic Press Ltd- Elsevier B.V. Ltd, v. 37, n. 4, p. 252-258, 2009.
Time Duration: 
252-258
Publisher: 
Academic Press Ltd Elsevier B.V. Ltd
Keywords: 
  • Thermostability
  • Protection
  • Newcastle disease vaccines
  • Commercial live vaccines
  • Virus vaccine
Source: 
http://dx.doi.org/10.1016/j.biologicals.2009.04.001
URI: 
Access Rights: 
Acesso restrito
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/2517
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.